Tuesday, October 27, 2020
Home Authors Posts by Editor / Curator

Editor / Curator

319 POSTS 0 COMMENTS
Biotech Stocks
Telehealth

Telehealth: How the Pandemic Forced Mental Health Care to Change for...

Editor / Curator -
Sorrento Theraputics, Biotech STock Review
Superbug News - CoronaVirus Watch List

Adding Sorrento Therapeutics (SRNE) to CoronaVirus Watch List.

Editor / Curator -
IPOS

Snowflake (SNOW) vs Facebook (FB) IPO.

Editor / Curator -
Telehealth

Mitesco Inc. Initiates “The Good Clinic” Rollout in Minneapolis; Introduces the...

Editor / Curator -
aPHEX bIOcLEANSE
Superbug News - CoronaVirus Watch List

Hy-IQ Trademark

Editor / Curator -
Biotech News

Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.

Editor / Curator -
2020 Watch List

Immunomedics (IMMU) $3.00 to $88, Up 29-fold, Our Second Best Idea...

Editor / Curator -
American BriVision
Biotech News

American BriVision’s (ABVC) Clinical Study Sparks Interest From Potential Partners.

Editor / Curator -
Internet Stock Review
Internet News

Peleton (PTON) Hits $25 Billion Valuation. Calm (Private) Hits Unicorn Valuation...

Editor / Curator -
Biotech News

Corbus Pharma (CRBP) Body Slammed -75%.

Editor / Curator -
1234...32Page 3 of 32

Latest article

Biosig

Adding BioSig (BSMG) $2.95 to Watch List.

Biotech News Editor / Curator -
Tough setback for newly launched Anti-Viral Endeavor ViralClear, Back to Business. LIVE QUOTE
roland rick perry

Can This Diabetes Drug Make you Smarter?

Biotech News Editor / Curator -
OKAY, maybe not make you smarter, but a new study out today says it may delay the onset of dementia - so...

Primer: Quantitative Easing, MMT, and Inflation/Deflation, Lyn Alden.

Stand Down Editor / Curator -
Quantitative easing (QE) occurs when central banks, such as the U.S. Federal Reserve, create new money to buy government bonds or other...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.